Full Text View
Tabular View
No Study Results Posted
Related Studies
Suramin and Paclitaxel in Treating Women With Stage IIIB or Stage IV Breast Cancer
This study has been completed.
Study NCT00054028   Information provided by National Cancer Institute (NCI)
First Received: February 5, 2003   Last Updated: July 23, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Additional conditions recognized in this trial
Breast Neoplasms
More general conditions related to this trial
Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
paclitaxel
suramin
More general drug interventions related to this trial
Anthelmintics
Anti-Infective Agents
Antimitotic Agents
Antinematodal Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Antiparasitic Agents
Antiprotozoal Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Trypanocidal Agents
Tubulin Modulators
Sponsors listed in this trial
Arthur G. James Cancer Hospital &Richard J. Solove Research Institute
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services